RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2010(21): 3645-3648
DOI: 10.1055/s-0030-1258258
DOI: 10.1055/s-0030-1258258
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
Limitations of the ‘Two-Phase’ Doebner-Miller Reaction for the Synthesis of Quinolines
Weitere Informationen
Received
22 July 2010
Publikationsdatum:
17. September 2010 (online)
Publikationsverlauf
Publikationsdatum:
17. September 2010 (online)
Abstract
The Doebner-Miller synthesis of quinolines under modified biphasic conditions was investigated. Crotonaldehyde, reacted readily with aniline to produce 2-methylquinoline. However, cinnamaldehyde and other γ-substituted α,β-unsaturated aldehydes yielded complex mixtures with substituted anilines to provide only trace quantities of quinolines. The Doebner-Miller reaction under these conditions is only suitable for sterically accessible α,β-unsaturated aldehydes.
Key words
α,β-unsaturated aldehyde - aniline - quinoline - Doebner-Miller reaction - heterocycle
- Supporting Information for this article is available online:
- Supporting Information
- 1
Bradley SG.Marciano-Cabral F. Antiparasitic Drugs, In Principles of PharmacologyMunson PL.Mueller RA.Breese GR. Chapman & Hall; New York: 1994. p.100 - 2
Clavier S.Rist O.Hansen S.Gerlach L.-O.Hogberg T.Bergman J. Org. Biomol. Chem. 2003, 1: 4248 -
3a
Michael JP. Nat. Prod. Rep. 2005, 22: 627 -
3b
Michael JP. Nat. Prod. Rep. 2004, 21: 650 -
4a
Glushkov RG.Levshin IB.Marchenko NB.Padeiskaya EN. Khim.-Farmatsevt. Zh. 1984, 18: 1048 -
4b
Hoemann MZ.Kumaravel G.Xie RL.Rossi RF.Meyer S.Sidhu A.Cuny GD.Hauske JR. Bioorg. Med. Chem. Lett. 2000, 10: 2675 -
4c
Wainwright M.Kristiansen JE. Int. J. Antimicrob. Agents 2003, 22: 479 -
5a
Yamashkin SA.Oreshkina EA. Chem. Heterocycl. Compd. 2006, 42: 701 -
5b
Kayukova LA.Praliev KD. Pharm. Chem. J. 2000, 34: 11 -
6a
O’Neill PM.Storr RC.Park BK. Tetrahedron 1998, 54: 4615 -
6b
Fotie J. Anti-Infect. Agents Med. Chem. 2006, 5: 357 -
6c
Egan TJ. Mini-Rev. Med. Chem. 2001, 1: 113 - 7
Kovaleva VL.Shilova EV.Poroikov VV. Pharm. Chem. J. 2003, 37: 293 - 8
Wu Y.Liu L.Li H.Wang D.Chen Y. J. Org. Chem. 2006, 71: 6592 -
9a
Denmark SE.Venkatraman S. J. Org. Chem. 2006, 71: 1668 -
9b
Eisch JJ.Dluzniewski T. J. Org. Chem. 1989, 54: 1269 -
10a
Skraup ZH. Ber. Dtsch. Chem. Ges. 1880, 2086 -
10b
Doebner O.von Miller W. Ber. Dtsch. Chem. Ges. 1883, 2464 - 11
Matsugi M.Tabusa F.Minamikawa J.-I. Tetrahedron Lett. 2000, 41: 8523 - 12
Sivaprasad G.Rajesh R.Perumal PT. Tetrahedron Lett. 2006, 47: 1783 - 13
Li XG.Cheng X.Zhou QL. Synth. Commun. 2002, 32: 2477 -
14a
Sato E. Chem. Pharm. Bull. 1990, 38: 1205 -
14b
Endo T.Saeki S.Hamana M. Chem. Pharm. Bull. 1981, 29: 3105 - 15
Calf GE.Samuel EL. Aust. J. Chem. 1963, 16: 833 - 16
Movassaghi M.Hill MD.Ahmad OK. J. Am. Chem. Soc. 2007, 129: 10096 - 17
Bertz SH.Dabbagh G. J. Org. Chem. 1990, 55: 5161 - 18
O’Murchu C. Synthesis 1989, 880 - 19
Crisp GT.Papadopoulos S. Aust. J. Chem. 1989, 42: 279 - 20
Sangu K.Fuchibe K.Akiyama T. Org. Lett. 2004, 6: 353 - 21
Movassaghi M.Hill MD. J. Am. Chem. Soc. 2006, 128: 4592 -
22a
Le Fevre RJW.Mathur FC. J. Chem. Soc. 1930, 2236 -
22b
Grigos VI.Povarov LS.Mikhailov BM.Zelinskii ND. Izv. Akad. Nauk SSSR, Ser. Khim. 1965, 2163 - 23
Sridharan V.Avendano C.Menendez JC. Tetrahedron 2007, 63: 673 - 24
Choi HY.Srisook E.Jang KS.Chi DY. J. Org. Chem. 2005, 70: 1222 - 25
Tahtaoui C.Guillier F.Klotz P.Galzi J.-L.Hibert M.Ilien B. J. Med. Chem. 2005, 48: 7847 - 26
Acheson RM.Flowerday RF. J. Chem. Soc., Perkin Trans. 1 1975, 394